1251 related articles for article (PubMed ID: 10342702)
1. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy.
Garly ML; Martins CL; Balé C; da Costa F; Dias F; Whittle H; Aaby P
Int J Epidemiol; 1999 Apr; 28(2):347-52. PubMed ID: 10342702
[TBL] [Abstract][Full Text] [Related]
2. Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age.
Aaby P; Andersen M; Sodemann M; Jakobsen M; Gomes J; Fernandes M
BMJ; 1993 Nov; 307(6915):1308-11. PubMed ID: 8257884
[TBL] [Abstract][Full Text] [Related]
3. Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa.
Benn CS; Aaby P; Balé C; Olsen J; Michaelsen KF; George E; Whittle H
Lancet; 1997 Jul; 350(9071):101-5. PubMed ID: 9228962
[TBL] [Abstract][Full Text] [Related]
4. Trial of high-dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy.
Aaby P; Jensen TG; Hansen HL; Kristiansen H; Thårup J; Poulsen A; Sodemann M; Jakobsen M; Knudsen K; Clotilde da Silva M
Lancet; 1988 Oct; 2(8615):809-11. PubMed ID: 2902263
[TBL] [Abstract][Full Text] [Related]
5. Child mortality following standard, medium or high titre measles immunization in West Africa.
Knudsen KM; Aaby P; Whittle H; Rowe M; Samb B; Simondon F; Sterne J; Fine P
Int J Epidemiol; 1996 Jun; 25(3):665-73. PubMed ID: 8671571
[TBL] [Abstract][Full Text] [Related]
6. Two-dose measles vaccination schedules.
Rosenthal SR; Clements CJ
Bull World Health Organ; 1993; 71(3-4):421-8. PubMed ID: 8324862
[TBL] [Abstract][Full Text] [Related]
7. Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine.
Garly ML; Balé C; Martins CL; Monteiro M; George E; Kidd M; Dias F; Aaby P; Whittle HC
Vaccine; 2001 Feb; 19(15-16):1951-9. PubMed ID: 11228365
[TBL] [Abstract][Full Text] [Related]
8. Expanded programme on immunization (EPI). Safety of high titre measles vaccines.
Wkly Epidemiol Rec; 1992 Nov; 67(48):357-61. PubMed ID: 1449986
[TBL] [Abstract][Full Text] [Related]
9. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study.
Aaby P; Garly ML; Balé C; Martins C; Jensen H; Lisse I; Whittle H
Pediatr Infect Dis J; 2003 Sep; 22(9):798-805. PubMed ID: 14506371
[TBL] [Abstract][Full Text] [Related]
10. Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine.
Whittle HC; Rowland MG; Mann GF; Lamb WH; Lewis RA
Lancet; 1984 Oct; 2(8407):834-7. PubMed ID: 6148572
[TBL] [Abstract][Full Text] [Related]
11. Effects of the introduction of new vaccines in Guinea-Bissau on vaccine coverage, vaccine timeliness, and child survival: an observational study.
Fisker AB; Hornshøj L; Rodrigues A; Balde I; Fernandes M; Benn CS; Aaby P
Lancet Glob Health; 2014 Aug; 2(8):e478-87. PubMed ID: 25103521
[TBL] [Abstract][Full Text] [Related]
12. Lessons from measles vaccination in developing countries.
Hall AJ; Cutts FT
BMJ; 1993 Nov; 307(6915):1294-5. PubMed ID: 8257878
[TBL] [Abstract][Full Text] [Related]
13. Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau.
Do VA; Biering-Sørensen S; Fisker AB; Balé C; Rasmussen SM; Christensen LD; Jensen KJ; Martins C; Aaby P; Benn CS
J Infect Dis; 2017 Apr; 215(8):1188-1196. PubMed ID: 28077730
[TBL] [Abstract][Full Text] [Related]
14. The effect of early measles vaccination at 4.5 months of age on growth at 9 and 24 months of age in a randomized trial in Guinea-Bissau.
Rasmussen SM; Biering-Sørensen S; Byberg S; Andersen A; Bjerregaard-Andersen M; Rodrigues A; Benn CS; Martins CL; Aaby P
BMC Pediatr; 2016 Dec; 16(1):199. PubMed ID: 27912735
[TBL] [Abstract][Full Text] [Related]
15. A general measles vaccination campaign in urban Guinea-Bissau: Comparing child mortality among participants and non-participants.
Byberg S; Thysen SM; Rodrigues A; Martins C; Cabral C; Careme M; Aaby P; Benn CS; Fisker AB
Vaccine; 2017 Jan; 35(1):33-39. PubMed ID: 27890397
[TBL] [Abstract][Full Text] [Related]
16. Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries.
Aaby P; Samb B; Simondon F; Seck AM; Knudsen K; Whittle H
BMJ; 1995 Aug; 311(7003):481-5. PubMed ID: 7647643
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B vaccination associated with higher female than male mortality in Guinea-bissau: an observational study.
Garly ML; Jensen H; Martins CL; Balé C; Baldé MA; Lisse IM; Aaby P
Pediatr Infect Dis J; 2004 Dec; 23(12):1086-92. PubMed ID: 15626943
[TBL] [Abstract][Full Text] [Related]
18. Increased female-male mortality ratio associated with inactivated polio and diphtheria-tetanus-pertussis vaccines: Observations from vaccination trials in Guinea-Bissau.
Aaby P; Garly ML; Nielsen J; Ravn H; Martins C; Balé C; Rodrigues A; Benn CS; Lisse IM
Pediatr Infect Dis J; 2007 Mar; 26(3):247-52. PubMed ID: 17484223
[TBL] [Abstract][Full Text] [Related]
19. Household experience and costs of seeking measles vaccination in rural Guinea-Bissau.
Byberg S; Fisker AB; Rodrigues A; Balde I; Enemark U; Aaby P; Benn CS; Griffiths UK
Trop Med Int Health; 2017 Jan; 22(1):12-20. PubMed ID: 27717100
[TBL] [Abstract][Full Text] [Related]
20. Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and yellow fever vaccines only. An observational study from Guinea-Bissau.
Fisker AB; Ravn H; Rodrigues A; Østergaard MD; Bale C; Benn CS; Aaby P
Vaccine; 2014 Jan; 32(5):598-605. PubMed ID: 24325827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
